Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oxaliplatin (eloxatin) (1 trial)
Raltitrexed (Tomudex) (1 trial)
Esophageal Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)